Drug Product Development For The Back Of The Eye Aaps Advances In The Pharmaceutical Sciences Series

Morningstar: BioSelective Capital Investments Completes Acquisition of BioDuro’s Irvine, California Drug Product Development and Manufacturing Operations

Drug Product Development For The Back Of The Eye Aaps Advances In The Pharmaceutical Sciences Series 1

BioSelective Capital Investments and Shayan Enterprises, LLC, a Utah-based risk-capital investment firm, today announced the successful acquisition of BioDuro’s drug product development and ...

BioSelective Capital Investments Completes Acquisition of BioDuro’s Irvine, California Drug Product Development and Manufacturing Operations

The company said its global HQ will remain in Irvine despite the transaction BioDuro last month announced the divestiture of its drug product development and manufacturing operations in Irvine. The ...

RAPS: AI in drug development: FDA draft guidance addresses product lifecycle, risk

Drug Product Development For The Back Of The Eye Aaps Advances In The Pharmaceutical Sciences Series 5

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Sitemap for Drugs.com website, with drug information, natural product information, medical dictionary and health encyclopedia alphabetical browse options

Drug Product Development For The Back Of The Eye Aaps Advances In The Pharmaceutical Sciences Series 7

BioTechniques: Rare disease drug development: challenges, support and hopes for the future

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...

The Desert Sun: Pyramid Pharma Services Announces Drug Product Manufacturing Agreement for Phio Pharmaceuticals’ Lead Oncology Candidate

Pyramid Pharma Services Announces Drug Product Manufacturing Agreement for Phio Pharmaceuticals’ Lead Oncology Candidate

To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...